Grosskurth, H

Habbema, JDF

Hayes, RJ

Kamali, A

Korenromp, EL

Orroth, KK

Serwadda, D

Sewankambo, NK

White, RG

Whitworth, JAG

English

LSHTM Research Online

A randomised controlled trial to determine the impact of

A randomized controlled trial in Tanzania to assess the impact of HSV-2 suppressive therapy on genital HIV viral load among HSV-2 and HIV-1 seropositive women. ISSTDR;

A review of its antiviral activity, pharmacokinetic properties and therapeutic efficacy in herpesvirus infections.

Antibody to HSV-2 as a marker of sexual risk behaviour in rural Tanzania.

Association between cervical shedding of herpes simplex virus and HIV-1.

Association of genital shedding of herpes simplex virus type 2 and HIV-1 among sex workers in rural Zimbabwe.

Behaviour change and competitive exclusion can explain the diverging HIV-1 and HIV-2 prevalence trends in GuineaBissau. Epidemiol Infect

Calculating the contribution of herpes simplex virus type 2 epidemics to increasing HIV incidence: treatment implications. Clin Infect Dis 2004;39(Suppl 5):S240–7.

Can behavior change explain increases in the proportion of genital ulcers attributable to herpes in sub-Saharan Africa? A simulation modeling study. Sex Transm Dis

Can population differences explain the contrasting results of the Mwanza, Rakai, and Masaka HIV/sexually transmitted disease intervention trials?: a modeling study.

Cervicovaginal HIV-1 and herpes simplex virus type 2 shedding during genital ulcer disease episodes.

Changes in plasma human immunodeficiency virus type 1 RNA associated with herpes simplex virus reactivation and suppression.

Determinants of the impact of sexually transmitted infection treatment on prevention of HIV infection: a synthesis of evidence from the Mwanza, Rakai, and Masaka intervention trials.

Development of clinically recognizable genital lesions among women previously identified as having ‘‘asymptomatic’’ herpes simplex virus type 2 infection. Ann Intern Med

Effect of aciclovir on HIV-1 acquisition in herpes simplex virus 2 seropositive women and men who have sex with men: a randomised, double-blind, placebo-controlled trial.

Empirical observations underestimate the proportion of human immunodeficiency virus infections attributable to sexually transmitted diseases in the Mwanza and Rakai sexually transmitted disease treatment trials: simulation results. Sex Transm Dis

Frequency of symptomatic and asymptomatic herpes simplex virus type 2 reactivations among human immunodeficiency virusinfected men.

Frequent recovery of HIV-1 from genital herpes simplex virus lesions in HIV-1-infected men.

Genital herpes and human immunodeficiency virus: double trouble. Bull World Health Organ

Genital herpes simplex virus type 2 shedding is increased in HIV-infected women in Africa.

Genital shedding of herpes simplex

Herpes simplex virus (HSV) suppression with valacyclovir reduces rectal and blood plasma HIV-1 levels in HIV-1/ HSV-2-seropositive men: a randomized, double-blind, placebo-controlled crossover trial.

Herpes simplex virus 2 infection increases HIV acquisition in men and women: systematic review and meta-analysis of longitudinal studies.

Herpes simplex virus suppressive treatment decreases plasma HIV-1 viral load in HSV-2/HIV-1 co-infected women: a randomized, placebo-controlled, cross-over trial. ISSTDR;

HIV spread and partnership reduction for different patterns of sexual behaviour: a study with the microsimulation model STDSIM.

HIV-1 seroconversion in a prospective study of female sex workers in northern Thailand: continued high incidence among brothel-based women.

Human immunodeficiency virus acquisition associated with genital ulcer disease and herpes simplex virus type 2 infection: a nested case-control study in Rakai, Uganda. JI n f e c tD i s2003;188:1492–7.

Impact of episodic acyclovir therapy on genital ulcer duration and HIV shedding from herpetic ulcers among men in South Africa.

Impact of HSV-2 episodic therapy on HIV-1 and HSV-2 genital shedding, and ulcer healing among women in Ghana and Central African Republic: randomised controlled trial

Impact of HSV-2 suppressive therapy on genital and plasma HIV-1 RNA in HIV-1 and HSV-2-seropositive women not taking ART: a randomized, placebo-controlled trial in Johannesburg, South Africa.

Interactions between herpes simplex virus type 2 and human immunodeficiency virus type 1 infection in African women: opportunities for intervention.

Interpreting sexual behaviour data: validity issues in the multicentre study on factors determining the differential spread of HIV in four African cities. AIDS 2001;15(Suppl 4):S117–26.

Investigations of the proportion of HIV infections attributable to sexually transmitted diseases in Sub-Saharan Africa based on data from the Mwanza and Rakai trials. London: London School of Hygiene and Tropical Medicine,

Male circumcision for HIV prevention in subsaharan Africa: who, what and when? AIDS

Multicentre study on factors determining differences in rate of spread of HIV in sub-Saharan Africa: methods and prevalence of HIV infection.

Organization. Guidelines for the management of sexually transmitted infections. Geneva: World Health Organization,

Potential effect of HIV type 1 antiretroviral and herpes simplex virus type 2 antiviral therapy on transmission and acquisition of HIV type 1 infection.

Prevalence and incidence of herpes simplex virus type 2 infection among male Zimbabwean factory workers.

Probability of HIV-1 transmission per coital act in monogamous, heterosexual, HIV-1-discordant couples in

Reduction of HIV-1 RNA levels with therapy to suppress herpes simplex virus.

Risk of human immunodeficiency virus infection in herpes simplex virus type 2-seropositive persons: a meta-analysis.

The effect of HIV, behavioural change, and STD syndromic management on STD epidemiology in sub-Saharan Africa: simulations of Uganda. Sex Transm Infect 2002;78(Suppl 1):i55–63.

The effect of suppressive acyclovir therapy on HIV cervicovaginal shedding in HIV- and HSV-2-infected women, Chiang Rai,

The effectiveness of HIV prevention strategies under alternative scenarios: evaluation with the STDSIM

The effects of herpes simplex virus-2 on HIV-1 acquisition and transmission: a review of two overlapping epidemics. J Acquir Immune Defic Syndr

The proportion of new HIV infections attributable to HSV-2 increases over time: simulations of the changing role of sexually transmitted infections in sub-Saharan African HIV epidemics. Sex Trans Infect 2007;83(Suppl 1):i17–24.

Treating curable sexually transmitted infections to prevent HIV in Africa: still an effective control strategy? J Acquir Immune Defic Syndr

Understanding differences across the contrasting epidemics in East and West Africa: results from a simulation model of the Four Cities Study. Sex Transm Infect 2007;83(Suppl 1):i5–16.

WeissH,Buve ´A,RobinsonN,etal.TheepidemiologyofHSV-2infectionanditsassociation with HIV infection in four urban African populations. AIDS 2001;15(Suppl 4):S97–108.

Higher risk behaviours and STD rates in Tanzania compared to Uganda - contribution to different outcomes of STD treatment trials? [abstract]

http://researchonline.lshtm.ac.uk/6964/1/U9G-84-S2-0012.pdf

Higher risk behaviours and STD rates in Tanzania compared to Uganda - contribution to different outcomes of STD treatment trials? [abstract]

Abstract

Similar works

Full text

Available Versions

LSHTM Research Online